Regeneron

President Trump was administered an investigative drug as part of his treatment for COVID-19. It's Regeneron's Regn-COV2, a combination of monoclonal antibodies. Here's what we know about it.
A science fair that recently took place wasn't giving out blue ribbons for homemade volcanoes. Rather, the projects were original research done by some of top-notch, high school talent, with the winners pocketing hefty cash awards. In the world of research, check out what this generation of future scientists finds both interesting and important.
The drug company, Regeneron, which specializes in biologicals (drugs made utilizing biological systems, such as antibodies, rather than synthesized chemicals), released results of a late-stage trial of their new man-made antibody, alirocumab. (Hopefully the brand name will roll off the tongue with a bit more fluidity).